The effect of (neo)adjuvant chemotherapy on long-term survival outcomes in patients with invasive lobular breast cancer treated with endocrine therapy: A retrospective cohort study.
Selin ÖztekinMaartje J HooningCarolien H M van DeurzenAnne-Marie H P DietvorstJan C DroogerJos J E M KitzenJohn W M MartensAnnemieke van der Padt-PruijstenMijntje B VastbinderHanneke ZuetenhorstBernadette Anna Maria Heemskerk-GerritsenAgnes JagerPublished in: Cancer (2023)
Chemotherapy is not associated with improved RFS, BCSS, or OS for patients with ER+/HER2- ILC treated with adjuvant endocrine therapy and with an indication for chemotherapy.